60 COPD Statistics, Trends & Insights [2025]

According to Statista, some world regions report significantly higher COPD case counts than others. Here's how global regions compare:

Source: Statista, Global COPD Cases by Region (accessed 2024)

This breakdown highlights how COPD is a global concern, particularly severe in Asia and Africa, where population density and pollution levels remain high. North America and Europe, while better equipped in terms of healthcare, still see high prevalence among older adults.

While overall case numbers paint a broad picture, age-specific prevalence reveals even more. According to BMC Public Health, adults aged 40 and older in certain regions face particularly high COPD rates. Here's how prevalence varies by WHO region:

Source: BMC Public Health, 2024. COPD prevalence among adults aged 40+ by WHO global regions

This data highlights major regional gaps. While the Americas and Southeast Asia face the steepest rates among older adults, Africa’s relatively lower figure may reflect underdiagnosis rather than lower disease burden.

COPD rates vary significantly across U.S. states, with some states showing nearly triple the national average. The table below highlights the prevalence of COPD across selected states in 2022.:

Source: CDC, 2024. State-level Estimates of COPD

The table highlights striking regional disparities in COPD rates, ranging from over 12% in some states to just 3% in others. The data shows that tackling COPD in the U.S. requires more than national strategies—it demands localized public health action where the burden is heaviest.

• COPD causes over 135,000 deaths each year in the U.S.

• The U.S. makes up about 4% of global COPD deaths.

• It was the 6th leading cause of death in the country.

• Before COVID-19, it was usually the 4th leading cause.

• The death rate from COPD is about 40–44 out of every 100,000 people.

• Differences in smoking, jobs, and healthcare access affect these numbers.

• From 1999 to 2021, the death rate for men dropped by 36%.

• For women, the rate started dropping around 2017 and is now down 15%.

• In 2021, more women (72,727) died from COPD than men (66,098).

• Although more women died from COPD in 2021, men still have a higher age-adjusted death rate.

• About 85% of COPD deaths happen in people aged 65 and older.

• Seniors, especially those over 75, have the highest death rates.

• Death rates in people aged 55–84 are going down.

• Although more women died from COPD in 2021, men still have a higher age-adjusted death rate.

Age-Specific COPD Mortality Rates in the U.S.:

Source: CDC, MMWR 2022; 71(49):1553–1558

This table highlights how sharply COPD mortality increases with age. Seniors aged 85 and above face a death rate more than ten times higher than those in the 65–74 age group, underscoring the vulnerability of older populations.

• White Americans have the highest COPD death rates.

• Asian and Pacific Islander Americans have the lowest.

• Men die from COPD more often than women in all racial groups.

When COPD gets worse, many people have to go to the emergency room (ER) often. Here are the main facts:

• In 2020, about 925,000 people in the U.S. visited the ER due to COPD — equivalent to279 visits per 100,000 people.
  (Source)

• Between 2006 and 2014, ER visits increased by around 4% annually, reflecting a growing disease burden during that period.
  (Source)

• After 2014, ER visits began to decline, with a notable drop by 2020. This decrease may be linked to better outpatient care or changes brought by the COVID-19 pandemic.
  (Source)

• Still, the numbers remain high: nearly 1 million ER visits every year underscore the ongoing impact of COPD on the healthcare system.
  (Source)

• Direct Medical Costs:
  COPD costs about $24–30 billion each year in the U.S. just for medical care.

• Where the Money Goes:

• • $11.9 billion on prescription drugs

• • $6.3 billion on hospital stays

• • $2.4 billion on doctor visits

• • $1.6 billion on home health care

• • $1.7 billion on ER and outpatient visits

(All figures from the American Lung Association)

• Per Patient Costs:
  Each person with COPD costs about $4,300 per year in medical bills. These costs have gone up 72% from 2000 to 2018, mainly due to rising medication prices.

• Future Costs:
  A study from Chest journal shows that COPD costs could hit $60.5 billion by 2029 as more people get older and need care.

• Indirect Costs:
  COPD also causes about $12 billion in lost productivity, early retirement, and the need for caregivers, making the total economic burden around $36 billion per year.

COPD is expensive for patients, families, and the entire healthcare system. Preventing COPD and managing it well (like through rehab and early care) can help save lives and money.

Many people with COPD need to go back to the hospital even after getting care. Here’s what the numbers show:

• In 2020, over 335,000 people in the U.S. were hospitalized mainly because of COPD.

• This means about 101 out of every 100,000 people had to stay in the hospital for COPD that year.

• Before 2020, the yearly number of COPD hospital stays was even higher—around 400,000 or more.

• The number dropped in 2020, partly because of COVID-19 safety measures like wearing masks and staying home.

• 1 in 5 people hospitalized for a serious COPD flare-up return to the hospital within 30 days.

• That’s a 20–23% readmission rate, one of the highest for any long-term illness.
  (Source)

• U.S. healthcare leaders are trying to lower these readmissions by encouraging better follow-up care and programs like pulmonary rehab.
  (Source)

• Smoking is the #1 cause of COPD in the U.S. and other wealthy countries.

• Around 75% of people with COPD have smoked before.

• Smoking causes nearly 8 out of 10 deaths from COPD.

• People who smoke now are 7 times more likely to get COPD than people who never smoked.

• Even secondhand smoke and other tobacco products (like cigars) raise the risk.

    Source: American Lung Association

• Breathing in dust, fumes, or chemicals at work can cause COPD.

• Jobs like mining, construction, factory work, farming, and cleaning are high-risk.

• Around 14% of COPD cases are from job-related air exposure, and this jumps to 31% in people who never smoked.

    Source: CDC

• Dirty air outside and inside can lead to COPD.

• Breathing in smoke from traffic or fires increases the risk.

• In poor countries, many people get COPD from indoor smoke while cooking with wood.

    Source: WHO

• Harmful lung infections in childhood (like pneumonia) can raise COPD risk.

• People with poor nutrition or uncontrolled asthma are also at higher risk.

• Getting older naturally weakens lung function.

• A rare genetic condition called Alpha-1 Antitrypsin Deficiency can cause COPD, even in people who never smoked.

• If someone has COPD at a young age or with little smoking history, they may be tested for this.

• This affects about 1% to 3% of COPD cases.

Quitting smoking is the best way to prevent COPD. But clean air, safe workplaces, and good lung health also matter. Public health efforts—like anti-smoking ads and clean-air laws—have helped make a difference.

COPD costs the U.S. government a lot, primarily through public health programs like Medicare and Medicaid.

• In 2019, total medical spending for COPD was $31.3 billion.

• Medicare paid $10.8 billion (34% of the total).

• Medicaid paid $3.0 billion (10%).

• Private insurers paid about $11.4 billion.

• The rest came from out-of-pocket and other sources.

(Source: PubMed - National and Local Direct Medical Cost Burden of COPD)

COPD costs are different in each state.

• In Alaska, costs were about $44.8 million per year.

• In Florida, they reached $3.1 billion.

(Source: PubMed - National and Local Direct Medical Cost Burden of COPD)

In every U.S. state, Medicare covers the most COPD hospital costs:

• Depending on the state, Medicare pays for 66% to 93% of COPD hospitalizations.

(Source: State and Insurance Type Variation in COPD – Journal of the COPD Foundation)

Medicare pays for most COPD care. This is because most patients are seniors. COPD also considerably strains public budgets, especially in states with more cases.

• Almost 50% of adults with COPD say their health stops them from doing regular things like cleaning, walking, or shopping.

• Only 17% of adults without COPD report the same problem.

    Source: PubMed

• 38% of people with COPD have trouble walking or using stairs.

• Only 11% without COPD have this issue.
  Why? COPD causes weak muscles and shortness of breath.

    Source: PubMed

• 24% of people with COPD cannot work because of their illness.

• That’s much higher than the 5% of adults without COPD who are unable to work.
  Reason: Tiredness, coughing, and breathing problems make it hard to keep a job.

    Source: PubMed

• 22% of COPD patients use things like oxygen tanks, walkers, or wheelchairs.

• Only 7% of people without COPD need such tools.

    Source: PubMed

A COPD.net patient impact survey reveals the real-world challenges faced by those living with COPD:

• 75% need help with daily tasks

• 49.6% limited in everyday activities

• 38% struggle with walking or stairs

• 24% unable to work due to COPD

• 22% use oxygen or mobility aids

• 52% experience anxiety or emotional distress

• 88% report COVID-19 worsened their mental health

Studies showed that people with COPD were more likely to get very sick from COVID-19:

• An extensive study from the UK found that people with COPD were 1.5 times more likely to be hospitalized or die from COVID-19 than those without COPD

(Source: BMJ Open Respiratory Research, 2021).

• A meta-analysis of global data showed that having COPD increased the risk of death from COVID-19 by 68%

This is likely because people with COPD already have lung damage and more inflammation in their bodies. Their lungs can't fight off the virus as well, which leads to worse outcomes.

People with COPD also faced long-term problems after getting COVID:

• One hospital study found that COPD patients who needed oxygen during their COVID illness were 12 times more likely to have “long COVID” symptoms weeks later.

• Long COVID affected 2.1% of COPD patients, compared to 1.2% of people without lung disease.

These long-term symptoms included tiredness, trouble breathing, cough, and chest pain. Some COPD patients saw their breathing get worse and had more flare-ups (called exacerbations) after COVID.

• A 2024 study in Scientific Reports showed that COPD patients who had severe COVID-19 lost lung function faster and had more frequent flare-ups afterward

• In rural communities, 8.2% of adults have COPD.

• In large cities, only 4.7% of adults have it.

• That means people in the countryside are almost twice as likely to have COPD.

    (Source: CDC)

• In rural counties, about 54.5 people per 100,000 die from COPD.

• In urban areas, that number is just 32.0 per 100,000.

So, the death rate in rural areas is over 70% higher than in cities.

Older adults living in rural counties are hospitalized more often for COPD than older adults in cities.

• This leads to higher healthcare costs and more serious health problems.

Several reasons explain the significant gap:

• Higher Smoking Rates: People in rural areas smoke more, which is a top cause of COPD.

• Dusty, Hazardous Jobs: Work in farming, mining, and construction often includes dust and chemicals that damage lungs.

• Less Access to Care:

• • Fewer lung doctors (pulmonologists).

• • Long travel times to hospitals.

• • Fewer clinics that offer early diagnosis or regular treatment.

To lower the burden in rural areas, the U.S. needs:

• More clinics and mobile care units.

• Help for people to quit smoking.

• Better training for rural doctors and nurses.

• Public education about lung health.

These numbers show a clear problem. People in rural areas are dying more often from a disease that can be managed. With the right help and resources, we can close this health gap.

• In 2020, about 479.86 million people worldwide had COPD.

• By 2050, this number is expected to rise to 591.6 million, an increase of nearly 23% over 30 years.

• Sub-Saharan Africa: Expected to have the highest COPD prevalence at 15.1%, affecting around 160 million people.

• North America: Projected prevalence of 13.5%.

• South Asia: Expected prevalence of 7.2%.​

• East Asia and the Pacific: Expected to have the highest number of male COPD cases at 77.2 million.

• South Asia: Projected to have 60.6 million male cases.​

• East Asia and the Pacific: Expected to have the highest number of female COPD cases at 46.4 million.

• South Asia: Projected to have 33.5 million female cases.​

• East Asia and the Pacific: Expected to face the largest economic loss due to COPD, estimated at $1,780 billion.

• North America: Projected economic impact of $1,073 billion.